EUVIMEDEUVIMED entdecken
Open Access

Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma

Matthias Preusser, Anna S Berghoff, Claudia Manzl, Martin Filipits, Andreas Weinhäusel, Walter Pulverer, Karin Dieckmann, Georg Widhalm, Adelheid Wöhrer, Engelbert Knosp, Christine Marosi, Johannes A Hainfellner

Clinical Neuropathology · 01.01.2014 · 33 (01) · 6-14

DOI: 10.5414/np300730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Neuropathology, erschienen am 01.01.2014. Verfasst von Matthias Preusser und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, Medical University of Vienna, Vienna, Division of Pathology, Medical University of Innsbruck, Innsbruck, Comprehensive Canc…. Hauptthemen laut MEDLINE: DNA Methylation, Promoter Regions, Genetic. Die Arbeit wurde bisher 46-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationPromoter Regions, GeneticAdultAgedBrain NeoplasmsDNA Modification MethylasesDNA Repair EnzymesDiphosphatesGlioblastomaHumansLuminescent MeasurementsNucleic Acid Amplification TechniquesPredictive Value of TestsReproducibility of ResultsSequence Analysis, DNASulfitesTumor Suppressor Proteins

Substanzen

DiphosphatesSulfitesTumor Suppressor Proteinsdiphosphoric acidDNA Modification MethylasesMGMT protein, humanDNA Repair Enzymeshydrogen sulfite

Autor:innen und Institutionen

  • Department of Medicine I, Medical University of Vienna, Vienna, Division of Pathology, Medical University of Innsbruck, Innsbruck, Comprehensive Cancer Center - CNS Tumors Unit (CCC-CNS), Medical University of Vienna, V…

Zitieren

APA

Preusser, M., Berghoff, A. S., Manzl, C., Filipits, M., Weinhäusel, A., Pulverer, W., Dieckmann, K., Widhalm, G., Wöhrer, A., Knosp, E., Marosi, C., & Hainfellner, J. A. (2014). Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma. Clinical Neuropathology, 33(01), 6-14. https://doi.org/10.5414/np300730

Vancouver

Preusser M, Berghoff AS, Manzl C, Filipits M, Weinhäusel A, Pulverer W, et al. Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma. Clinical Neuropathology. 2014;33(01):6-14. doi:10.5414/np300730

BibTeX
@article{Preusser2014,
  author = {Preusser, Matthias and Berghoff, Anna S and Manzl, Claudia and Filipits, Martin and Weinhäusel, Andreas and Pulverer, Walter and Dieckmann, Karin and Widhalm, Georg and Wöhrer, Adelheid and Knosp, Engelbert and Marosi, Christine and Hainfellner, Johannes A},
  title = {Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma},
  journal = {Clinical Neuropathology},
  year = {2014},
  volume = {33},
  number = {01},
  pages = {6--14},
  doi = {10.5414/np300730}
}
Kostenlos starten →